Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2016
ADVERSE REACTIONS
Post-marketing Experience
Immune System Disorders: Hypersensitivity with the manifestations of rash..
Menu
